skip to Main Content

Tumor Tip of the Week – yc Staging

Scenario:  01-01-2021 core biopsy rectum+ moderately differentiated adenocarcinoma, clinical stage cT3 cN0 cM0 Stage 2A.  Patient undergoes neoadjuvant chemoradiation. Prior to surgery, endoscopy showed no residual tumor, thus did not go on to further surgical resection. Question:  Can you assign…

Read More

Tumor Tip of the Week – Bridge Therapy

Note the new COVID fields & text requirements-for 2020+ [once available in your software] Scenario:  03-15-2020 needle biopsy right breast infiltrating ductal carcinoma grade 2 ER+PR+HER2+ [1.2cm on mammogram] 03-17-2020 Due to Covid-19 started on hormonal therapy until surgery can…

Read More

Tumor Tip of the Week – Coding Lung Histology

Scenario: 10-01-2020 FNA RUL: adenocarcinoma 10-30-2020 RUL Lobectomy: Histology: adenocarcinoma, acinar predominant (acinar 60%, solid predominant 20%, lepidic predominant 20%) Question:  How would you assign histology? 8140 Adenocarcinoma 8551 Acinar adenocarcinoma / Adenocarcinoma, acinar predominant 8230 Solid adenocarcinoma / Adenocarcinoma,…

Read More

Tumor Tip of the Week-pM1 Stage & Grade

Scenario: (Biopsy proven Rectum primary with biopsy proven mets to liver) Colonoscopy biopsy rectum+ moderately differentiated adenocarcinoma.  Needle biopsy of liver + metastatic adenocarcinoma, CT/EUS show clinical T3, clinical N1 case. No resection is done, patient has pathologically confirmed mets…

Read More

Tumor Tip of the Week-Ovarian Grade

Scenario:  06-18-2020 Ovarian primary TAH/BSO- endometrioid adenocarcinoma-FIGO grade 1, however, focal areas (1-2%) with high nuclear grade, consistent with FIGO grade 2 Question:  How would the pathological grade be coded? 1 G1: Well differentiated 2 G2: Moderately differentiated 3 G3:…

Read More
Back To Top
×Close search
Send this to a friend